Despite the reported clinical relevance of TCF12 and MALAT1 in CRC malignancy [5,32], their individual overexpression in the patient cohort from The Cancer Genome Atlas—Colon Cancer (TCGA-COAD) dataset does not show a significant association with poorer prognosis. This evidence concerns the gene TCF12 and colorectal carcinoma.